Tag: Pharmaceutical Industry
Kura Oncology Licenses Leukemia Drug to Japanese Drugmaker
Kura Oncology and the Japanese drugmaker Kyowa Kirin have joined forces in a global partnership to work on Kura’s new treatment for acute leukemia. The drug, ziftomenib, is currently in a late-stage clinical trial...
Assessing the Cost-Effectiveness of Alzheimer’s Drug Donanemab in the U.K.
The recent decision by the U.K.'s National Institute for Health and Care Excellence (NICE) regarding the cost-effectiveness of the Alzheimer's drug Donanemab, also known as Kisunla, has raised concerns about its accessibility to patients....
Expanding Access to HIV Prevention Drug: ViiV Faces Criticism
ViiV Healthcare recently announced plans to increase access to its HIV prevention medication in low- and middle-income countries. This marks the second time in two years that the company has taken such steps. Despite...
Pfizer CEO’s Vision for Leading Cancer and Obesity Treatments
Albert Bourla, the CEO of Pfizer, is looking to shift the focus of the company from its successful COVID-19 vaccine and antiviral Paxlovid to new investments in drugs for cancer and obesity. While Pfizer's...
FDA Requests Further Research before Approving MDMA Therapy
The Food and Drug Administration (FDA) recently declined to approve MDMA-assisted therapy for the treatment of post-traumatic stress disorder (PTSD), citing insufficient data to support its use. The FDA requested additional clinical trials to...
New FDA-Approved Overdose-Reversal Medication by Purdue Pharma
Purdue Pharma, infamous for its role in the opioid crisis, has received FDA approval for a new auto-injector device designed to reverse opioid overdoses. The device, known as Zurnai, uses nalmefene, a potent version...
Moderna’s Ongoing Impact from Covid: What to Expect
Moderna's Covid Impact ContinuesModerna, the company responsible for developing one of the first Covid vaccines, has faced challenges in the wake of the pandemic. Despite a successful year with high stock prices and the...